JP2017527558A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017527558A5 JP2017527558A5 JP2017511190A JP2017511190A JP2017527558A5 JP 2017527558 A5 JP2017527558 A5 JP 2017527558A5 JP 2017511190 A JP2017511190 A JP 2017511190A JP 2017511190 A JP2017511190 A JP 2017511190A JP 2017527558 A5 JP2017527558 A5 JP 2017527558A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- composition
- item
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462043084P | 2014-08-28 | 2014-08-28 | |
| US62/043,084 | 2014-08-28 | ||
| PCT/US2015/047405 WO2016033444A1 (en) | 2014-08-28 | 2015-08-28 | Compositions, methods and kits for treating complement related disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019186857A Division JP6811821B2 (ja) | 2014-08-28 | 2019-10-10 | 補体関連障害を処置するための組成物、方法およびキット |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017527558A JP2017527558A (ja) | 2017-09-21 |
| JP2017527558A5 true JP2017527558A5 (https=) | 2018-10-04 |
| JP6651506B2 JP6651506B2 (ja) | 2020-02-19 |
Family
ID=55400647
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017511190A Active JP6651506B2 (ja) | 2014-08-28 | 2015-08-28 | 補体関連障害を処置するための組成物、方法およびキット |
| JP2019186857A Active JP6811821B2 (ja) | 2014-08-28 | 2019-10-10 | 補体関連障害を処置するための組成物、方法およびキット |
| JP2020207487A Active JP7275095B2 (ja) | 2014-08-28 | 2020-12-15 | 補体関連障害を処置するための組成物、方法およびキット |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019186857A Active JP6811821B2 (ja) | 2014-08-28 | 2019-10-10 | 補体関連障害を処置するための組成物、方法およびキット |
| JP2020207487A Active JP7275095B2 (ja) | 2014-08-28 | 2020-12-15 | 補体関連障害を処置するための組成物、方法およびキット |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US10813977B2 (https=) |
| EP (2) | EP3892291A1 (https=) |
| JP (3) | JP6651506B2 (https=) |
| AU (1) | AU2015308773B2 (https=) |
| ES (1) | ES2872537T3 (https=) |
| WO (1) | WO2016033444A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2843684A1 (en) * | 2010-08-13 | 2012-02-16 | Tufts University | Compositions, kits and methods for treatment of macular degeneration using soluble membrane-independent cd59 protein |
| EP3892291A1 (en) | 2014-08-28 | 2021-10-13 | Tufts University | Compositions, methods and kits for treating complement related disorders |
| GB201608046D0 (en) * | 2016-05-09 | 2016-06-22 | Cambridge Entpr Ltd And Syndey Children S Hospitals Network Randwick And Westmead Incorporating The | Treatment of complement-mediated disorders |
| EP3573665A4 (en) * | 2017-01-27 | 2020-11-11 | Board Of Supervisors Of Louisiana State University | BIFUNCTIONAL SMALL PEPTIDE FOR AUTOIMMUN DIABETES |
| CN109331186B (zh) * | 2018-10-10 | 2022-04-05 | 华南师范大学 | 一种脂质体修饰的金纳米粒复合物及其在治疗帕金森氏症方面的应用 |
| WO2020213004A1 (en) * | 2019-04-13 | 2020-10-22 | National Centre For Cell Science | Daf-mcp chimeric proteins, process to manufacture the same and use of the chimeric protein for treating pathological conditions involving the complement system |
| EP4355886A1 (en) * | 2021-06-18 | 2024-04-24 | Ikarovec Limited | Retinal disorders |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4405712A (en) | 1981-07-01 | 1983-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | LTR-Vectors |
| US4650764A (en) | 1983-04-12 | 1987-03-17 | Wisconsin Alumni Research Foundation | Helper cell |
| AU4404785A (en) | 1984-05-25 | 1985-12-31 | Dana-Farber Cancer Institute, Inc. | Ltr vectors, methods of preparation and use |
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US4861719A (en) | 1986-04-25 | 1989-08-29 | Fred Hutchinson Cancer Research Center | DNA constructs for retrovirus packaging cell lines |
| US4980289A (en) | 1987-04-27 | 1990-12-25 | Wisconsin Alumni Research Foundation | Promoter deficient retroviral vector |
| CA1315719C (en) | 1988-02-05 | 1993-04-06 | Arthur Bank | Retroviral packaging cell lines and processes of using same |
| US5112767A (en) | 1988-03-04 | 1992-05-12 | University Of Southern California | Vectors with enhancer domains |
| CA1339354C (en) | 1988-09-01 | 1997-08-26 | The Whitehead Institute For Biomedical Research | Recombinant retroviruses with amphotropic and ecotropic host ranges |
| WO1990002797A1 (en) | 1988-09-15 | 1990-03-22 | North Carolina State University | Self-inactivating, replication defective, retroviral vectors and helper cells for producing the same |
| US5124263A (en) | 1989-01-12 | 1992-06-23 | Wisconsin Alumni Research Foundation | Recombination resistant retroviral helper cell and products produced thereby |
| WO1990013641A1 (en) | 1989-05-10 | 1990-11-15 | Sloan-Kettering Institute For Cancer Research | Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter |
| EP1285967A3 (en) | 1990-09-21 | 2005-03-02 | Chiron Corporation | Human retroviral packaging cell line |
| JP3249516B2 (ja) | 1990-10-31 | 2002-01-21 | ソマティクス セラピー コーポレイション | 遺伝子治療のためのレトロウイルスのベクター |
| US5122767A (en) | 1991-01-10 | 1992-06-16 | Northern Telecom Limited | Saw device tapped delay lines |
| DE69131908T3 (de) | 1991-02-19 | 2008-04-03 | Oxford Biomedica (Uk) Ltd. | Viruspartikel mit veraendertem wirtspektrum |
| AU3434393A (en) | 1992-01-17 | 1993-08-03 | Regents Of The University Of Michigan, The | Targeted virus |
| US5627264A (en) | 1994-03-03 | 1997-05-06 | Alexion Pharmaceuticals, Inc. | Chimeric complement inhibitor proteins |
| US5851826A (en) | 1995-07-26 | 1998-12-22 | Children's Medical Center Corporation | Helper virus-free herpesvirus vector packaging system |
| US5843884A (en) | 1995-11-15 | 1998-12-01 | Oklahoma Medical Research Foundation | C9 complement inhibitor |
| US7166568B1 (en) | 1998-02-09 | 2007-01-23 | Oklahoma Medical Research Foundation | Compositions and methods to inhibit formation of the C5b-9 complex of complement |
| US6689600B1 (en) | 1998-11-16 | 2004-02-10 | Introgen Therapeutics, Inc. | Formulation of adenovirus for gene therapy |
| WO2012016162A2 (en) * | 2010-07-29 | 2012-02-02 | Tufts University | Compositions, methods and kits for modeling, diagnosing, and treating complement disorders |
| JP5697027B2 (ja) * | 2008-02-15 | 2015-04-08 | タフツ ユニバーシティー | マウス網膜上への細胞膜傷害複合体（ｍａｃ）生成のヒト化モデル、並びに、黄斑変性の処置のための組成物とキットと方法 |
| US8877896B2 (en) * | 2008-02-15 | 2014-11-04 | Tufts University | Compositions, methods and kits for modeling, diagnosing, and treating complement disorders |
| AU2014209350B8 (en) * | 2013-01-23 | 2019-04-18 | Department Of Veterans Affairs (Us) | Targeting constructs based on natural antibodies and uses thereof |
| US9617940B2 (en) | 2014-08-14 | 2017-04-11 | General Electric Company | Engine diagnostic system and an associated method thereof |
| EP3892291A1 (en) | 2014-08-28 | 2021-10-13 | Tufts University | Compositions, methods and kits for treating complement related disorders |
-
2015
- 2015-08-28 EP EP21161633.9A patent/EP3892291A1/en active Pending
- 2015-08-28 JP JP2017511190A patent/JP6651506B2/ja active Active
- 2015-08-28 EP EP15836880.3A patent/EP3186269B1/en active Active
- 2015-08-28 WO PCT/US2015/047405 patent/WO2016033444A1/en not_active Ceased
- 2015-08-28 ES ES15836880T patent/ES2872537T3/es active Active
- 2015-08-28 AU AU2015308773A patent/AU2015308773B2/en active Active
-
2017
- 2017-02-28 US US15/444,500 patent/US10813977B2/en active Active
-
2019
- 2019-10-10 JP JP2019186857A patent/JP6811821B2/ja active Active
-
2020
- 2020-10-09 US US17/067,515 patent/US11654179B2/en active Active
- 2020-12-15 JP JP2020207487A patent/JP7275095B2/ja active Active
-
2023
- 2023-05-19 US US18/199,616 patent/US20230414714A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017527558A5 (https=) | ||
| JP7324253B2 (ja) | 補体媒介性疾患を処置するための組成物及び方法 | |
| JP7275095B2 (ja) | 補体関連障害を処置するための組成物、方法およびキット | |
| JP2018537087A5 (https=) | ||
| JP2020019813A5 (https=) | ||
| JP2015518479A5 (https=) | ||
| UA120917C2 (uk) | Химерний білок фактора viii та його застосування | |
| KR20220010478A (ko) | 기도 감염의 치료 또는 예방용 서브유닛 백신 | |
| JP6650515B2 (ja) | 高親和力の可溶性ｐｄｌ−１分子 | |
| JP2013502226A5 (https=) | ||
| JP2021522790A5 (https=) | ||
| JP2020533969A5 (https=) | ||
| JP2014506450A5 (https=) | ||
| JP2020172505A5 (https=) | ||
| JP2018537089A5 (https=) | ||
| JP2017521074A5 (https=) | ||
| US20230090422A1 (en) | Novel coronavirus s protein double-region subunit nano-vaccine based on bacterial complex | |
| JP2016513471A5 (https=) | ||
| KR20220106981A (ko) | 재조합 cdkl5 단백질, 유전자 치료 및 생산 방법 | |
| JP2017538443A5 (https=) | ||
| CN105658228A (zh) | 结合人类补体c5的稳定多肽 | |
| WO2017202394A1 (zh) | 用于防治阿尔茨海默病的融合蛋白及其制备方法和应用 | |
| Sugita et al. | CD59: its role in complement regulation and potential for therapeutic use | |
| AU2020368012A1 (en) | Compounds for immunomodulation | |
| KR101756131B1 (ko) | 간세포 성장인자 및 기질세포 유발인자1알파를 이용한 말초동맥질환의 예방 또는 치료용 조성물 |